about
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesAlemtuzumab in the treatment of multiple sclerosis: patient selection and special considerationsCopper phenotype in Alzheimer's disease: dissecting the pathwayThe Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsThe role of the cerebellum in multiple sclerosis.Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US surveyAge independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.Relapses and disability accumulation in progressive multiple sclerosisRadiologically isolated syndrome: 5-year risk for an initial clinical event.No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple SclerosisA longitudinal model for disease progression was developed and applied to multiple sclerosis.Therapeutic Advances and Future Prospects in Progressive Forms of Multiple SclerosisMortality in patients with multiple sclerosisAnalysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.Multiple sclerosis: experimental models and reality.Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.Mitochondrial sirtuins--a new therapeutic target for repair and protection in multiple sclerosis.Multiple sclerosis: individualized disease susceptibility and therapy response.Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations.Work-related problems in multiple sclerosis: a literature review on its associates and determinants.Long-term disability and progression in spinal onset multiple sclerosis.Early predictive factors of disability in CIDP.Late onset multiple sclerosis: concerns in aging patients.Aging and multiple sclerosis.Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study.Age Related Multiple Sclerosis Severity Score: Disability ranked by age.Disability and progression in Afro-descendant patients with multiple sclerosis.Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous SystemAutologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice.Contribution of different relapse phenotypes to disability in multiple sclerosis.
P2860
Q26748229-7DDA72F3-82E4-4054-85AC-3B55271DD356Q28077000-50E5D4C5-FE34-4306-A2FB-E4F15930BF0DQ28294380-746D8127-8486-4599-B87C-A057703F7F59Q28601505-60833389-FFEC-41D2-B66E-AB394933C36CQ30884001-642B7870-EF4D-4B60-B3C7-B29BF7B789A4Q33643239-645B05AB-6160-4408-AD5F-26177905FB26Q33719214-F0A0B2DB-1A98-4DB8-93C3-A90C1C82C394Q33741396-0CC67927-4B11-4F19-A23F-ABBA9C6B0E39Q34295012-D7B32CE7-5FD5-47DC-A8FE-78BF6BADD103Q34613311-27F6F10C-923B-4CF3-A1EA-BEA13713FA87Q35106567-C509F767-0E95-4D5C-B4FC-E749E666E22AQ35112019-E2BAF947-8704-4C32-AFAF-CC81356E6F44Q35604215-4D9B23E6-0853-4729-87A9-BD940E184AFAQ36005655-E9650E1A-A041-4D3E-867C-BFC2C654218EQ36062456-2FAC6D6A-379D-4F29-9B79-AC9CCA981ECFQ36075481-09DA7C9E-B36A-4E63-9F50-5AE246098F33Q36179420-6BBA638F-3CE4-48EC-8EA7-14C9DF20E079Q36204696-81371671-BB48-4B6F-8D4F-10B97B95C3DAQ36275639-FCD06183-C4FC-4EBC-9E57-B67689FCC1F8Q36484443-A950A244-9113-456A-A65A-60DE10C0FC40Q37163309-C2BF7344-4AE2-4E2C-9641-D55783B69EAFQ37433538-888B27C6-C1D8-4AA5-AF28-D282F563F99FQ37596784-5E795E60-F622-459A-A9AD-C1935A4F6F07Q37599583-DCF3ABC8-8978-4394-BDD6-E149B88CF03FQ38009295-962D9BCD-EF9D-42A0-A505-51A4183412C6Q38019568-56D7658A-EDC9-48C6-8D47-208FA385201AQ38079620-7A9FD9B9-58C5-4C4E-B494-8F09BC637593Q38212039-B24A888B-2984-4C1B-A4EE-19DE684B002EQ38554887-387D6423-A0C9-48CA-955B-66F3511993CDQ38622652-6DA9C096-72F7-45C2-9BCF-037F5D442BF9Q38645214-D66768DC-3041-42EB-9BF1-B154F18D24D0Q38660110-BCCF2B4B-FFD0-4980-B05D-98C1E6694CF7Q38741396-3D40B271-EAB8-4E8C-8B2B-D20E3AF073EFQ38758444-ACEA2E69-7314-484B-9970-E91F715D993DQ38982429-C107FEB2-FFFE-4B7F-A66F-9C5B74746229Q38985395-8ADFE5CE-0CE7-4966-BC87-0C64113E8A06Q39335873-BA8388DE-C4CC-4270-82C8-CEC94EF0C230Q39378263-550FD642-9A33-4D9A-B94C-8ED895A4C2F8Q39623663-9CF64D0C-251C-4697-8682-5D8C76F9860FQ40724148-1FC06EF0-02D7-4FE4-8DAC-0FD567FFAEC6
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Age and disability accumulation in multiple sclerosis.
@ast
Age and disability accumulation in multiple sclerosis.
@en
type
label
Age and disability accumulation in multiple sclerosis.
@ast
Age and disability accumulation in multiple sclerosis.
@en
prefLabel
Age and disability accumulation in multiple sclerosis.
@ast
Age and disability accumulation in multiple sclerosis.
@en
P2093
P2860
P1433
P1476
Age and disability accumulation in multiple sclerosis.
@en
P2093
P2860
P304
P356
10.1212/WNL.0B013E318230A17D
P407
P577
2011-09-14T00:00:00Z